000			01299 a2200349 4500
005			20250515231403.0
264		0	_c20101015
008			201010s 0 0 eng d
022			_a1558-3147
024	7		_a10.1016/j.psc.2010.04.008 _2doi
040			_aNLM _beng _cNLM
100	1		_aGanasen, K A
245	0	0	_aAugmentation of cognitive behavioral therapy with pharmacotherapy. _h[electronic resource]
260			_bThe Psychiatric clinics of North America _cSep 2010
300			_a687-99 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAnimals
650	0	4	_aAnti-Anxiety Agents _xtherapeutic use
650	0	4	_aAnxiety Disorders _xdrug therapy
650	0	4	_aCognitive Behavioral Therapy _xmethods
650	0	4	_aCombined Modality Therapy _xmethods
650	0	4	_aCycloserine _xpharmacology
650	0	4	_aDrug Therapy _xmethods
650	0	4	_aExtinction, Psychological _xdrug effects
650	0	4	_aHumans
650	0	4	_aRandomized Controlled Trials as Topic
650	0	4	_aSubstance-Related Disorders _xdrug therapy
700	1		_aIpser, J C
700	1		_aStein, D J
773	0		_tThe Psychiatric clinics of North America _gvol. 33 _gno. 3 _gp. 687-99
856	4	0	_uhttps://doi.org/10.1016/j.psc.2010.04.008 _zAvailable from publisher's website
999			_c19945790 _d19945790